Doug Schenkel
Stock Analyst at Wolfe Research
(3.61)
# 766
Out of 4,840 analysts
66
Total ratings
54.17%
Success rate
33.87%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Outperform | $60 | $65.87 | -8.91% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $62.17 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $29.41 | +104.01% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $22.84 | +22.59% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $211.02 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $122.54 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $2.24 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $189.18 | +50.65% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $37.15 | - | 2 | Sep 30, 2024 | |
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $111.26 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $43.85 | +17.45% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $8.59 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $82.49 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $56.56 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $403.55 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.15 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $92.23 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $0.91 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $13.15 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $39.17 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $157.16 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $358.36 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.90 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.72 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.68 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.44 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.96 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.28 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.55 | +605.88% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $21.48 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $326.64 | -72.45% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.09 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $228.62 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $85.33 | -81.25% | 2 | Sep 28, 2017 |
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $65.87
Upside: -8.91%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $62.17
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $29.41
Upside: +104.01%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $22.84
Upside: +22.59%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $211.02
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $122.54
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $2.24
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $189.18
Upside: +50.65%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $37.15
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $111.26
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $43.85
Upside: +17.45%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $8.59
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $82.49
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $56.56
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $403.55
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $4.15
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $92.23
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $0.91
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $13.15
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $39.17
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $157.16
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $358.36
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.90
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.72
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.68
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.44
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.96
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $3.28
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.55
Upside: +605.88%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $21.48
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $326.64
Upside: -72.45%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $5.09
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $228.62
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $85.33
Upside: -81.25%